Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gateways to clinical trials.

M Bayés1, X Rabasseda, J R Prous

  • 1Prous Science, S.A., Barcelona, Spain. mbayes@prous.com

Methods and Findings in Experimental and Clinical Pharmacology
|December 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A report from the World Conference on Lung Cancer (September 6-9, 2015 - Denver, Colorado, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the American Association of Urology Annual Meeting 2015 (May 15-19 - New Orleans, Louisiana, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 73rd Annual Meeting of the American Academy of Dermatology (March 20-24 - San Francisco, California, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the European Association for the Study of the Liver's 50th International Liver Congress (April 22-26 - Vienna, Austria).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 (February 23-26--Seattle, Washington, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 2014 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting (November 14-19 - Boston, Massachusetts, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same journal

[Proceedings of the XVIII TASPE Seminar, Granada, Spain, 4-5 February 2010].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment algorithm for gastrointestinal graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Classification of chronic graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Pegfilgrastim in hematopoietic stem cell transplantation].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Allogeneic transplantation in multiple myeloma patients: results and recommendations in February 2010].

Methods and findings in experimental and clinical pharmacology·2011
See all related articles

This guide summarizes recent clinical trials for numerous drugs, including those for cancer, infectious diseases, and cardiovascular conditions. It provides a comprehensive overview of ongoing research and development in pharmaceutical and biotechnological fields.

Area of Science:

  • Pharmaceutical Sciences
  • Clinical Research
  • Biotechnology

Context:

  • Compiles data from the Clinical Trials Knowledge Area of Prous Science Integrity.
  • Focuses on a wide selection of drugs currently in literature and congresses.
  • Serves as a guide to the most recent advancements in clinical trials.

Purpose:

  • To provide an updated overview of ongoing clinical trials.
  • To highlight key drugs and therapeutic areas under investigation.
  • To facilitate access to information on drug discovery and development.

Summary:

  • Features a comprehensive list of drugs, including (-)-Epigallocatechin gallate, adalimumab, aripiprazole, atorvastatin, bevacizumab, bortezomib, cetuximab, dasatinib, erlotinib hydrochloride, gefitinib, human papillomavirus vaccine, imatinib mesylate, insulin detemir, insulin glargine, insulin glulisine, intranasal insulin, ivabradine hydrochloride, lapatinib, natalizumab, nilotinib, omalizumab, panitumumab, peginterferon alfa-2a, peginterferon alfa-2b, pegvisomant, pemetrexed disodium, posaconazole, prasugrel, pregabalin, rosuvastatin calcium, sirolimus-eluting stent, sorafenib, tadalafil, telmisartan/hydrochlorothiazide, temsirolimus, tigecycline, tipifarnib, tramiprosate, vardenafil hydrochloride hydrate, vorinostat, and zotarolimus-eluting stent.

Related Experiment Videos

  • Data is sourced from Prous Science Integrity's Clinical Trials Knowledge Area.
  • Covers a broad spectrum of therapeutic categories and drug classes.

    • Impact:

    • Aids researchers, clinicians, and industry professionals in staying abreast of clinical trial progress.
    • Supports informed decision-making in drug development and therapeutic strategies.
    • Enhances discoverability of emerging treatments and research trends.